DE2229311A1 - 2,3-Dihydrochinobenzoxazepine und -thiazepine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel - Google Patents

2,3-Dihydrochinobenzoxazepine und -thiazepine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Info

Publication number
DE2229311A1
DE2229311A1 DE19722229311 DE2229311A DE2229311A1 DE 2229311 A1 DE2229311 A1 DE 2229311A1 DE 19722229311 DE19722229311 DE 19722229311 DE 2229311 A DE2229311 A DE 2229311A DE 2229311 A1 DE2229311 A1 DE 2229311A1
Authority
DE
Germany
Prior art keywords
general formula
compounds according
compounds
solution
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722229311
Other languages
German (de)
English (en)
Inventor
Harry Louis New Brunswick; Petigara Ramesh Somerset; NJ. YaIe (V.StA.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of DE2229311A1 publication Critical patent/DE2229311A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/18—[b, e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/14—[b, e]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19722229311 1971-06-24 1972-06-15 2,3-Dihydrochinobenzoxazepine und -thiazepine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel Pending DE2229311A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15655771A 1971-06-24 1971-06-24

Publications (1)

Publication Number Publication Date
DE2229311A1 true DE2229311A1 (de) 1972-12-28

Family

ID=22560065

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722229311 Pending DE2229311A1 (de) 1971-06-24 1972-06-15 2,3-Dihydrochinobenzoxazepine und -thiazepine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Country Status (8)

Country Link
US (1) US3784548A (enExample)
JP (2) JPS5724356B1 (enExample)
CA (1) CA978524A (enExample)
CH (2) CH553810A (enExample)
DE (1) DE2229311A1 (enExample)
FR (1) FR2143423B1 (enExample)
GB (1) GB1388582A (enExample)
HU (1) HU163951B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966762A (en) * 1974-06-03 1976-06-29 Sterling Drug Inc. N-[6,7]-Dihydroindolo[1,7-ab][1]benzazepin-2-yl)methyl/phthalimide

Also Published As

Publication number Publication date
HU163951B (enExample) 1973-11-28
CA978524A (en) 1975-11-25
CH553810A (fr) 1974-09-13
FR2143423A1 (enExample) 1973-02-02
FR2143423B1 (enExample) 1975-10-17
US3784548A (en) 1974-01-08
GB1388582A (en) 1975-03-26
JPS5724356B1 (enExample) 1982-05-24
JPS56135487A (en) 1981-10-22
CH553809A (fr) 1974-09-13

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2614406C2 (enExample)
DE2111071B2 (de) 4-(l-Alkyl-4-piperidyliden)-4H-benzo[43] cyclohepta [1,2-b] thiophen-10 (9H)-one bzw. -9 (lOH)-one, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2165260A1 (de) Verfahren zur Herstellung von N-substituierten Dibenzo eckige Klammer auf b,f eckige Klammer zu thiepin-10-methylaminen und zugehörige neue Zwischenprodukte
EP0185909B1 (de) 5-Alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2512109A1 (de) Hexahydro-gamma-carbolinderivate, deren salze, verfahren zu ihrer herstellung und arzneipraeparate
DE1695132A1 (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
EP0019172A1 (de) 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel
DE69319859T2 (de) Neue tetracyclische verbindungen
DE2051962A1 (de) Benzimidazo eckige Klammer auf l,2d eckige Klammer zu eckige Klammer auf 1,4 eckige Klammer zu benzodiazepin 6 (5H) one und Verfahren zu deren Her stellung
DE2314639A1 (de) Pharmakodynamisch aktive aminoalkyloximaether
DE2229311A1 (de) 2,3-Dihydrochinobenzoxazepine und -thiazepine, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1470139C3 (de) 5,11-Dihydrodibenz eckige Klammer auf b,e eckige Klammer zu-1,4-oxazepine und Verfahren zu ihrer Herstellung
DE2745742A1 (de) Piperidylidenderivate von benzoxanthenen, -thioxanthenen und -dibenzoxepinen, verfahren zu deren herstellung und deren verwendung als psychopharmaca
DE1695812B2 (de) Dibenzo [cfl -1,2-thiazepin-derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitung
DE2456098B2 (de) Xanthen- und Thioxanthen-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2238776A1 (de) 1,2-dihydrochinobenzoxa-(oder thia)zepin-3-on-oximderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2143646A1 (de) 2-Amino-l,5-benzodiazocinderivate und Verfahren zu ihrer Herstellung
DE1695844C3 (de) l-Phenyl-23,43-tetrahydro-lH^benzazepin-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
DE3700825A1 (de) 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
DE2304729A1 (de) 3-aminoalkyloxy-2,3-dihydrochinobenzoxazepine oder -thiazepine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
CH505850A (de) Verfahren zur Herstellung von neuen Benzoxazepinonen
DE2448259A1 (de) Verfahren zur herstellung von 2-halogenmethyl-1,4-benzodiazepinen
DE2711656A1 (de) Neue pyridin-3-ole
DE2846880A1 (de) Substituierte chinolizidin- und indolizidinmethanolderivate, verfahren zur herstellung derselben und arzneimittel, welche diese enthalten

Legal Events

Date Code Title Description
OHA Expiration of time for request for examination